Alpelisib Market Report: Trends, Insights, and Forecast for 2030

According to the study by Next Move Strategy Consulting, the rising cases of menopausal women coupled with the lack of awareness regarding the treatment of menopause that leads to hot flashes, sleep disruption, and vaginal dryness is expected to further propel the growth of alpelisib market.

It is a protein kinase inhibitor that is a type of enzyme inhibitor that blocks the actions of protein kinases, which further helps to block certain cancer cells and also blocks the growth of new blood vessels to treat cancer.

In addition, it is used in patients whose cancer got worse after treatment with hormone therapy. It is also used in the treatment of thalassemia and to treat patients undergoing leukemia by maintaining the required cell growth.

Request FREE Sample PDF: https://www.nextmsc.com/alpelisib-market/request-sample